Why it’s Breakthrough: It’s a sensor that’s ingested and adds “intelligence” to pharmaceuticals, giving patients up-to-the-second information about the body’s health and well-being. And that information can be retrieved securely to a cell phone via the internet.

The Story: Proteus Biomedical Inc., makes products that keep us informed. “Proteus has developed a unique approach to personalizing therapy,” said Andrew Thompson, Proteus CEO and co-founder. “We embed micro-sensors into existing drugs and devices, which transmit information, securely, to a person’s cell phone via the Internet. A person can understand how their body is responding to their therapy, and, if they choose, share this information with a family member, physician or friend to help them stay healthy.”

About Proteus Biomedical

Proteus Biomedical is pioneering intelligent medicine, an emerging field of advanced therapeutics that integrates in-body computer, sensor and communications technologies into existing medical device and pharmaceutical products. Proteus’s proprietary computing and sensing technologies enable proven therapies to be personalized, offering broad potential benefits across a range of care settings and therapeutic areas including cardiovascular, psychiatric, metabolic and neurologic disorders. The company’s first products, novel pacing and sensor-enabled devices for Cardiac Resynchronization Therapy, are in development in collaboration with world leaders in cardiovascular implantable devices.

http://www.proteusbiomed.com